Moderna said recently that Swiss drugs regulator Swissmedic had authorised the use of its COVID-19 vaccine for children aged six to 11 years.
The approval is for the vaccine’s two-dose series of 50 micro gram per dose, Moderna added.
Edits by EP News Bureau